Jun 26, 2026 03:50AM
Jun 25, 2026 06:49AM
Jun 18, 2026 06:49AM
May 21, 2026 06:35AM
Apr 7, 2026 11:00AM
Mar 31, 2026 05:19AM
Jan 12, 2026 08:09AM Connect Biopharma reports new mechanism data for rademikibart drug
Dec 1, 2025 08:47AM
Nov 14, 2025 09:00AM
Nov 12, 2025 05:09PM
Oct 31, 2025 06:05AM
Oct 30, 2025 08:30AM
Sep 30, 2025 06:53AM
Sep 3, 2025 08:03AM Connect Biopharma ends ADR program, lists ordinary shares on NASDAQ
Jul 22, 2025 09:15AM
Jul 22, 2025 08:55AM
Jul 21, 2025 09:02AM
Jul 9, 2025 09:02AM
Jun 13, 2025 09:01AM
Jun 10, 2025 04:38PM
May 13, 2025 09:08AM Connect Biopharma (CNTB) Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
Apr 11, 2025 09:00AM
Apr 1, 2025 09:02AM
Apr 1, 2025 06:51AM
Mar 31, 2025 04:05PM
Mar 28, 2025 04:06PM
Sep 6, 2024 06:56AM
Jun 12, 2024 04:15PM Connect Biopharma (CNTB) Appoints Barry Quart as CEO, David Szekeres as President

423,925 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All